Mirae Asset Global Etfs Holdings Ltd. Gossamer Bio, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 103,947 shares of GOSS stock, worth $267,143. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,947Holding current value
$267,143% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
136Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$47.2 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$46.5 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$29.3 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$20.7 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$18.4 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $241M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...